Kusajili – Clinical trials directory

Result of your search per sponsor: Medical University of Vienna / Medizinische Universität Wien

Woman and Man Max 99 years
Medical University of Vienna / Medizinische Universität Wien Update Il y a 5 ans

Effects of once-daily administered GLP-1 Receptoragonist Lixisenatide in combination with basal Insulin on glycemic control in patients with type-2 diabetes mellitus not achieving therapeutic targets with premixed insulin strategy Introduction of basal insulin therapy in combination with the GLP-1 receptor agonist Lixisenatide in patients with type-2 diabetes previously treated with premixed insulin not achieving therapeutic ta...

Country None
organs None
Specialty None

Closed trial

More information